Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice

Recently, accumulating evidence has suggested that gut microbiota may be involved in the occurrence and development of ankylosing spondylitis (AS). It has been suggested that rifaximin have the ability to modulate the gut bacterial communities, prevent inflammatory response, and modulate gut barrier...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Infect Microbiol
Main Authors: Yang, Lianjun, Liu, Bin, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Liu, Jinshi, Su, Zhihai, Wang, Min, Cui, Zhifei, Wang, Tingxuan, Zhang, Weicong, Li, Qingchu, Lu, Hai
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Cellular and Infection Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6409347/
https://ncbi.nlm.nih.gov/pubmed/30886835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2019.00044
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados